Monoclonal Antibody Treatments
The federal government has issued emergency use authorization for monoclonal antibodies. These can be given to high-risk, COVID-positive patients to help reduce the risk of hospitalization and emergency room visits.
These treatments are most effective if given early in the disease process, soon after the onset of COVID-19 symptoms.
Because doses are limited, eligible patients are randomly selected each day and given the option of receiving the treatment the following day. If we have available appointments, patients may be offered a same-day appointment.
Eligible patients must be:
- COVID positive AND
- Within 8 days from their onset of symptoms AND
- Not hospitalized AND
- Greater than 65 years old OR
- Greater than 55 years old with other comorbidities including chronic kidney disease, diabetes, or other immunosuppressive diseases or treatments OR
- Less than 55 years old with specific comorbidities
This treatment is given through an infusion, and it takes about 2-3 hours.
If you feel you qualify for this treatment, talk to your primary care physician right away about a referral. If you have any questions, email your name, phone number and questions to COVID19@slhduluth.com.